Gregory C Issing
Examiner (ID: 7200, Phone: (571)272-6973 , Office: P/3646 )
Most Active Art Unit | 2202 |
Art Unit(s) | 3642, 3662, 2202, 3646 |
Total Applications | 2605 |
Issued Applications | 1868 |
Pending Applications | 137 |
Abandoned Applications | 600 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18725793
[patent_doc_number] => 20230340011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/305332
[patent_app_country] => US
[patent_app_date] => 2023-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 211265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 1159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18305332
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/305332 | STEROIDAL COMPOSITIONS AND METHODS OF TREATING LIPOGENIC CANCERS | Apr 21, 2023 | Pending |
Array
(
[id] => 18709101
[patent_doc_number] => 20230331693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => GSPT1 COMPOUNDS AND METHODS OF USE OF THE NOVEL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/300315
[patent_app_country] => US
[patent_app_date] => 2023-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18300315
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/300315 | GSPT1 COMPOUNDS AND METHODS OF USE OF THE NOVEL COMPOUNDS | Apr 12, 2023 | Pending |
Array
(
[id] => 18565622
[patent_doc_number] => 20230255949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => BENZIMIDAZOLE DERIVATIVES COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/166020
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166020
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166020 | BENZIMIDAZOLE DERIVATIVES COMPOSITIONS | Feb 7, 2023 | Pending |
Array
(
[id] => 18451401
[patent_doc_number] => 20230192679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/083222
[patent_app_country] => US
[patent_app_date] => 2022-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18083222
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/083222 | CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | Dec 15, 2022 | Pending |
Array
(
[id] => 19425051
[patent_doc_number] => 12084453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Bicyclic amines as CDK12 inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/064173
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51581
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7826
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18064173
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/064173 | Bicyclic amines as CDK12 inhibitors | Dec 8, 2022 | Issued |
Array
(
[id] => 18391313
[patent_doc_number] => 20230159531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => HTT MODULATORS FOR TREATING HUNTINGTON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/988340
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17988340
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/988340 | HTT MODULATORS FOR TREATING HUNTINGTON'S DISEASE | Nov 15, 2022 | Pending |
Array
(
[id] => 18466853
[patent_doc_number] => 20230201133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => Isomer-Specific Neuroprotective Effect of Natural Resveratrol
[patent_app_type] => utility
[patent_app_number] => 17/974680
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17974680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/974680 | Isomer-Specific Neuroprotective Effect of Natural Resveratrol | Oct 26, 2022 | Pending |
Array
(
[id] => 18335912
[patent_doc_number] => 20230127861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS USING VOLASERTIB
[patent_app_type] => utility
[patent_app_number] => 17/972963
[patent_app_country] => US
[patent_app_date] => 2022-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17972963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/972963 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS USING VOLASERTIB | Oct 24, 2022 | Pending |
Array
(
[id] => 18326238
[patent_doc_number] => 20230124366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => CANCER TREATMENT USING FGFR INHIBITORS AND PLK1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/046648
[patent_app_country] => US
[patent_app_date] => 2022-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046648
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046648 | Cancer treatment using FGFR inhibitors and PLK1 inhibitors | Oct 13, 2022 | Issued |
Array
(
[id] => 18483505
[patent_doc_number] => 20230210802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => COMPOSITION FOR RELIEVING HANGOVER AND IMPROVING LIVER FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/729691
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/729691 | COMPOSITION FOR RELIEVING HANGOVER AND IMPROVING LIVER FUNCTION | Apr 25, 2022 | Pending |
Array
(
[id] => 18239965
[patent_doc_number] => 20230072276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => Azaquinazoline pan-KRas inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/300930
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 149124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300930
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/300930 | Azaquinazoline pan-KRas inhibitors | Dec 14, 2021 | Pending |
Array
(
[id] => 18077295
[patent_doc_number] => 20220402907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/360699
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 123911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 414
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17360699
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/360699 | MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE | Jun 27, 2021 | Pending |
Array
(
[id] => 16948060
[patent_doc_number] => 20210206751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => Rotomeric Isomers of 4-alkyl-5-Heteroaryl-3H-1,2-Dithiole-3-Thiones
[patent_app_type] => utility
[patent_app_number] => 17/205841
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205841
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/205841 | Rotomeric Isomers of 4-alkyl-5-Heteroaryl-3H-1,2-Dithiole-3-Thiones | Mar 17, 2021 | Pending |
Array
(
[id] => 17928340
[patent_doc_number] => 20220323465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => PHARMACEUTICAL COMBINATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/287071
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -83
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287071
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287071 | PHARMACEUTICAL COMBINATION AND USE THEREOF | Dec 3, 2020 | Pending |
Array
(
[id] => 17385564
[patent_doc_number] => 20220033416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => COMPOUNDS USEFUL TO TREAT INFLUENZA VIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/297407
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17297407
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/297407 | COMPOUNDS USEFUL TO TREAT INFLUENZA VIRUS INFECTIONS | Jul 9, 2020 | Pending |
Array
(
[id] => 17428307
[patent_doc_number] => 20220056015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => KIF18A INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/416415
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 795
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416415 | KIF18A INHIBITORS | Dec 19, 2019 | Pending |
Array
(
[id] => 17460199
[patent_doc_number] => 20220073504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => KIF18A INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/416411
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 710
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416411 | KIF18A INHIBITORS | Dec 19, 2019 | Pending |
Array
(
[id] => 17343582
[patent_doc_number] => 20220009913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => SMALL MOLECULE INHIBITORS OF GALECTIN-3
[patent_app_type] => utility
[patent_app_number] => 17/299325
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299325
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299325 | SMALL MOLECULE INHIBITORS OF GALECTIN-3 | Dec 3, 2019 | Pending |
Array
(
[id] => 17685746
[patent_doc_number] => 20220193038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/299270
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299270 | COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION | Dec 2, 2019 | Pending |
Array
(
[id] => 17426730
[patent_doc_number] => 20220054438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => KCHIP2 MODULATOR COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/299573
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299573 | KCHIP2 MODULATOR COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | Dec 2, 2019 | Pending |